YOU WERE LOOKING FOR :ENVIRONMENTAL FORCES AND PHARMACEUTICAL ENVIRONMENT
Essays 301 - 330
In ten pages this paper examines the drug manufactured by Eisai Pharmaceutical, Inc. along with the marketing strategies that affe...
In five pages this report considers how the pharmaceutical industry has benefited from technological development in this considera...
In twelve pages this paper examines how the pharmaceutical industry can utilize business to business marketing in a consideration ...
orchestrated our growing dependence on prescription drugs. Big Pharma now represents a practically inescapable component ...
of the countries in Africa that have this problem; any difficult-to-eradicate disease can take its toll on a governments resources...
for the firm to start increasing the level of expenditure on research and development. To determine the most appropriate strategy ...
grew from an average of seven in 1993 to an average of eleven in 2000 to an average of twelve in 2004 (Critser, 2007). At the tim...
someone worker through the harvest season, the landowners could not summarily fire him during the winter; and, likewise, the farme...
A five stage model looking at problem recognition, information search, evaluation of alternatives, purchase decision, and post- pu...
that the company always come out looking good, no matter how egregious their business practices may be. We have seen that too ofte...
Patents cover such things as chemicals, "pharmaceutical formulations, methods of making chemicals and methods of treating patients...
be accessed remotely is already a key element of data that can be accessed by physicians, allowing them to gain up to date researc...
lavish parties for physicians on a regular basis, to incite them to prescribe the companys drugs more often (Trevino & Nelson, 200...
emotional appeal, where marketers have sought to appeal to either negative or positive emotions with attempts to find the right em...
organization appears to be satisfied that the goal is reached, with the organization operating in a unified manner across the glob...
for the stockholders with a strategy that diversified risk with presences in many different markets, a strategy that had operated ...
the new advertising venues. This trend has been reflected in pharmaceutical companies as well, for whom online advertising has bee...
will attempt to draw several broad projections about the future of the industry, based on an in-depth examination of emerging biot...
be benefiting from increased stability, in the last decade with the government appears to have reduced inflation and placed this u...
this once giant drug company is definitely suffering a mid-life crisis. Background Merck, which is headquartered in Whiteho...
and it sells Zantac under the Warner-Lambert name, another acquisition (Hoovers, 2002). It was Warner-Lambert who manufactured Lip...
(or at least to help reduce the side effects of this immune deficiency disease). The reality of the situation is, however, ...
industry average is 9.91%, and for Pfizer is still lower, but gives different results, this time of 8.54. This may also be seen as...
just came on the market. This paper will demonstrate that this difficult career can be rewarding as it provides a worthwhile livin...
The drug that ImClone hopes to hang its hat on is Erbitux, which was developed to target and block Epidermal Growth Factor Recepto...
demand and unemployment. When Ronald Reagan entered office, he initiated his famous "supply side" economic theory with its "trickl...
likely not endear the FDA to elderly people who at this point cannot afford medication and are forced to go over the border to pur...
the "government should subsidize prescription drug spending for all 40 million Americans over the age of 65 - whether they need it...
care issues will explore the relationship between European think tanks and the multinational pharmaceutical companies, specificall...
In six pages this paper discusses the pharmaceuticals industry in terms of increased government regulation with Glaxo Wellcome's A...